水胶体敷料

Search documents
奥美医疗收购洛曼劳仕集团中国区业务 进一步深化战略合作
Zheng Quan Shi Bao Wang· 2025-07-31 13:43
Core Viewpoint - Aomei Medical has signed a comprehensive cooperation agreement with Lohmann & Rauscher Group, marking a significant strategic partnership that includes the acquisition of Lohmann & Rauscher's wholly-owned subsidiary in China and exclusive agency rights for various medical products in the region [1][2]. Group 1: Strategic Partnership - The partnership involves Aomei Medical acquiring 100% of Lohmann & Rauscher (China) Medical Supplies Co., Ltd. and gaining exclusive agency rights for wound management, pressure treatment, and external fixation products in China [1]. - This collaboration is a continuation of their strategic cooperation that began with a functional dressing business partnership in November 2024, further solidifying their multi-layered strategic alliance [1][2]. Group 2: Market Position and Product Development - Aomei Medical has been focusing on the research and manufacturing of functional dressings, launching innovative products such as soft silicone foam dressings and hydrocolloid dressings, which cater to various wound care scenarios [2]. - The partnership enhances Aomei Medical's product pipeline in the wound management sector and allows entry into new fields like pressure treatment and external fixation, significantly boosting its competitive edge in the Chinese market [2]. Group 3: Leadership Perspectives - The CEO of Lohmann & Rauscher Group expressed confidence that the partnership will lead to higher quality and more sustainable product development, highlighting Aomei Medical's production capabilities [2]. - Aomei Medical's chairman emphasized that this collaboration marks a new beginning in the healthcare sector, aiming for significant achievements in expanding their market presence in China [3].
全球与中国褥疮类药物市场现状及未来发展趋势2025-2031
QYResearch· 2025-04-28 09:30
随着人口老龄化问题的加剧,长期卧床的老年患者、残障患者及重病患者数量增多,导致褥疮的发生率上升。褥疮不仅是一个公共健康 问题,也给医疗系统和患者带来了巨大的负担。因此,治疗褥疮的药物和敷料需求持续增长。 产品种类丰富 目前治疗褥疮的药物主要分为两大类:敷料类和抗生素类药膏。敷料类产品包括水胶体敷料、泡沫敷料、银离子敷料等,主要用于创面 保护和促进愈合;抗生素药膏如莫匹罗星软膏、红霉素软膏等,用于防治创面感染。随着科技进步,越来越多的新型敷料(如生物可降 解敷料)和具有抗菌、促进愈合作用的药物投入市场,治疗效果不断提升。 褥疮类药物是指用于预防、治疗和管理因长时间压力导致的皮肤及皮下组织损伤(即褥疮或压疮)的一类药物和护理产品。这些药物和 产品旨在减轻疼痛、控制感染、促进伤口愈合,并尽量减少并发症的发生。本报告统计范围包括患者中最常用的褥疮敷料和抗生素药 膏。 褥疮类药物行业目前现状分析 市场需求增长 技术创新推动行业发展 新技术和新材料的应用,尤其是水凝胶、泡沫敷料和银离子敷料等高科技产品,使得治疗褥疮的效果更加显著。这些产品具有更好的吸 湿性、抗菌性和创面保护性,改善了患者的使用体验和治疗效果。同时,生物医 ...